Price $4.72 |
Market Cap
186.5M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
1.47
|
P/S
0.36
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
2.0
|
Op. Cash Flow
99.8K
|
FCF
2.2
|
|
Op. Margin
-42.70%
|
Net Margin
-38.20%
|
ROE
-91.30%
|
ROI
3.30%
|
|
ROA
-19.40%
|
EPS Growth
-508.70%
|
Current Ratio
2.1
|
Debt/Equity
195.70%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Myriad Genetics, Inc. (MYGN) | $31.45 | - | - | 2.41B | Strong Buy |
| Cumberland Pharmaceuticals, In (CPIX) | $3.39 | - | - | 43M | Strong Buy |
| Genesis Healthcare Inc (GENN) | $0.25 | - | - | 53.6M | Strong Buy |
| La Jolla Pharmaceutical Compan (LJPC) | $3.74 | - | - | 113.5M | Strong Buy |
| Predictive Technology Group In (PRED) | $0.21 | - | - | 131.8M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
